Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

Journal of Clinical Investigation

Volumn 115, Issue 5, 2005, Pages 1343-1351

  Donnelly, Kerry L ^a   Smith, Coleman I ^a,b   Schwarzenberg, Sarah J ^a,c   Jessurun, Jose ^a,c   Boldt, Mark D ^a,b   Parks, Elizabeth J ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Minnesota Gastroenterology   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; ISOTOPE; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; FAT INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; LIPID LIVER LEVEL; LIPID STORAGE; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; LIVER BIOPSY; MALE; MASS SPECTROMETRY; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; SECRETION;

EID: 18244382304     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI23621     Document Type: Article

References (50)

1. Ludwig, J., Viggiano, T.R., McGill, D.B., and Oh, B.J., 1980. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherco unnamed disease. Mayo Clinic. Proc. 55:434-438.
2. Clark, J.M., Brancati, F.L., and Diehl, A.M. 2002. Nonalcoholic fatty liver disease. Gastroenterology. 122:1649-1657.
3. Lee, R.G. 1989. Nonalcoholic steatohepatiris: a study of 49 patients. Hum. Path. 20:594-598.
4. Bacon, B.R., Farahvash, M.J., Janney, C.G., and Neuschwander-Tetri, B.A. 1994. Nonalcoholic steatoheparitis: an expanded clinical entity. Gastroenterology. 107:1103-1109.
5. James, O., and Day, C. 1999. Non-alcoholic steatohepariris: another disease of affluence. Lancet. 353:1634-1636.
6. Sanyal, A.J. 2002. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology. 123:1705-1725.
7. Marchesini, G., et al. 1999. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107:450-455.
8. Marchesini, G., et al. 2001. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 50:1844-1850.
9. Parks, E.J., Krauss, R.M., Christiansen, M.P., Neese, R.A., and Hellerstein, M.K. 1999. Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production and clearance. J. Clin. Invest. 104:1087-1096.
10. Chen, Y.I., Golay, A., Swislocki, A.L.M., and Reaven, G.M. 1987. Resistance to insulin suppression of plasma free fatty acid concentrations and insulin stimulation of glucose uptake in noninsulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 64:17-21.
11. Kooner, J.S., et al. 1998. Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 18:1021-1026.
12. Frayn, K.N., and Coppack, S.W. 1992. Insulin resistance, adipose tissue and coronary heart disease. Clin. Sci. 82:1-8.
13. Sanyal, A.J., et al. 2001. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 120:1183-1192.
14. Miles, J.M., et al. 2004. Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids. Diabetes. 53:521-527.
15. Havel, R.J., and Hamilton, R.L. 2004. Hepatic catabolism of remnant lipoproteins: where the action is. Arterioscler. Thromb. Vasc. Biol. 24:213-21 5.
16. Farquhar, J.W., Gross, R.C., Wagner, R.M., and Reaven, G.M. 1965. Validation of an incompletely coupled two-compartment nonrecycling caternary model for turnover of liver and plasma triglyceride in man. J. Lipid Res. 6:119-134.
17. Reaven, G.M., Hill, D.B., Gross, R.C., and Farquhar, J.W. 1965. Kinetics of triglyceride turnover of very low-density lipoproteins in human plasma. J. Clin. Invest. 44:1826-1833.
18. Diraison, F., Moulin, P.H., and Beylot, M. 2003. Contribution of hepatic de novo lipogenesis and reesterification of plasma nonesterified fatty acid to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 29:478-485.
19. Donnelly, K.L., Margosian, M.R., Sheth, S.S., Lusis, A.J., and Parks, E.J. 2004. Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip-/-mice. J. Nutr. 134:1475-1480.
20. Donnelly, K.L., Smith, C.l., Schwarzenberg, S.J., Boldt, M.D., and Parks, E.J. 2004. Stable isotope methodology to identify sources of fat in liver biopsy tissue from patients with non-alcoholic fatty liver disease. Diabetes. 56:A53.
21. Dixon, A.K. 1983. Abdominal fat assessed by computed tomography: sex difference in distribution. Clin. Radiol. 34:189-191.
22. Matthews, D.R., et al. 1985. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:412-419.
23. Timlin, M.T., and Parks, E.J. 2005. The temporal pattern of de novo lipogenesis in the postprandial state. Am. J. Clin. Nutr. 81:35-42.
24. Horton, J.D., Goldstein, J.L., and Brown, M.S. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109:1125-1131. doi:10.1172/JCI200215593.
25. Laurell, S., and Lundquist, A. 1971. Lipid composition of human liver biopsy specimens. Acta Med. Scand. 189:65-68.
26. Martinsson, A., Sunzell, H., and Hood, B. 1963. Nitrogen, lipid, glycogen and deoxyribonucleic acid content of human liver. Acta Med. Scand. 173:745-752.
27. Marchesini, G., et al. 2001. Metformin in non-alcoholic steatohepatitis. Lancet. 358:893-894.
28. Caldwell, S.H.,et al. 2001. A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. Am. J. Gastroenterol. 96:519-525.
29. Vajro, P., et al. 1994. Persistent hyperaminotransferasemia resolving after weight reduction in obese children. J. Pediatr. 125:239-241.
30. Bajaj, M., et al. 2003. Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes. Diabetes. 52:1364-1370.
31. Promrat, K., et al. 2004. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology. 39:188-196.
32. Schwarz, J.-M., Linfoot, P., Dare, D., and Aghajanian, K. 2003. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am. J. Clin. Nutr. 77:43-50.
33. Parks, E.J. 2002. Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations. Br. J. Nutr. 87(Suppl. 2):S247-S253.
34. Hudgins, L.C., et al. 2000. Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. J. Lipid Res. 41:595-604.
35. Miles, J.M., et al. 2004. Systemic and forearm triglyceride metabolism: fate of lipoprotein lipase-generated glycerol and free fatty acids. Diabetes. 53:521-527.
36. Barrows, B.R., and Parks, E.J. 2004. Fatty acid contribution to very-low density lipoprotein triacylglycerol (VLDL-TG) during fasted and postprandial states in healthy males. Diabetes. 56:A1388.
37. Timlin, M.T., and Parks, E.J. 2004. Study of fatty acid sources contributing to VLDL-triglyceride (TG) postprandially using multiple stable isotopes. Diabetes. 56:A338.
38. Baar, R.A., et al. 2005. Investigation of in vivo fatty acid metabolism in AFABP/aP2 -/- mice. Am. J. Physiol. 288:E187-E193.
39. Baker, N. 1969. The use of computers to study rates of lipid metabolism. J. Lipid Res. 10:1-24.
40. Patterson, B.W. 1997. Use of stable isotopically labeled tracers for studies of metabolic kinetics: an overview. Metabolism. 46:322-329.
41. Boberg, J., Carlson, L.A., and Freyschuss, U. 1972. Determination of splanchnic secretion rate of plasma triglycerides and of total and splanchnic turnover of plasma free fatty acids in man. Eur. J. Clin. Invest. 2:123-132.
42. Nilsson, S., and Schersten, T. 1969. Synthesis of phospholipids and triglyceride in human liver slices. Scand. J. Clin. Lab. Invest. 24:237-249.
43. Charlton, M., Sreekumar, R., Rasmussen, D., Lindor, K., and Nair, K.S, 2002. Apolipoprotein synthesis in nonalcoholic steatohepatitis. Hepatology. 35:898-904.
44. Yoshizumi, T., et al. 1999. Abdominal fat: standardized technique for measurement at CT. Radiology. 211:283-286.
45. Dixon, J.B., Bhathal, P.S., and O'Brien, P.E. 2001. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 121:91-100.
46. Marzetta, C.A., Foster, D.M., and Brunzell, J.D. 1990. Conversion of plasma VLDL and IDL precursors into various LDL subpopulations using density gradient ultracentrifugation. J. Lipid Res. 31:975-984.
47. Folch, J., Lees, M., and Sloane Stanley, G.H. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
48. Hellerstein, M.K., Neese, R.A., and Schwarz, J.M. 1993. Model for measuring absolute rates of hepatic de novo lipogenesis and reesterification of free fatty acids. Am. J. Physiol. 265:E814-E820.
49. Hellerstein, M.K. 1995. Methods for measurement of fatty acid and cholesterol metabolism. Curr. Opin. Lipidol. 6:172-181.
50. Wolfe, R.R. 1992. Radioactive and stable isotope tracers in biomedicine. John Wiley & Sons Inc. New York, New York, USA. 471 pp.